Back to search

Article

Biomarker driven drug repurposing for Fuchs’ Endothelial Corneal Dystrophy (FECD): A Computational study

2024-08-26

Abstract excerpt

<title>Abstract</title> <p>Fuchs’ Endothelial Corneal Dystrophy (FECD) is a slowly advancing, non-inflammatory eye condition due to gradual increase in thickness of the Descemet’s membrane and the gradual decline in corneal endothelial cells population. It can occur sporadically or be inherited in an autosomal dominant manner leading to impaired vision over time. The only available method to treat FECD is corneal...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f7298285-30c5-56f2-bead-a825e4dc64ee
DOI
10.21203/rs.3.rs-4820986/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Biomarker driven drug repurposing for Fuchs’ Endothelial Corneal Dystrophy (FECD): A Computational studyDOI 10.21203/rs.3.rs-4820986/v1
Select a neighboring publication to make it the new centre.